Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle
doi: 10.3389/fphys.2021.717550 Received 31 May 2021 Accepted 19 July 2021 Published 19 August 2021 Volume 12 - 2021 Edited by Zhihong Yang, Universit de Fribourg, Switzerland Reviewed by Xiu-Fen Ming, Universit de Fribourg, Switzerland
Protected from light and moisture
Food and Drug Administration (FDA) for medical use in humans
What TB-500 Is and Why the Dosage Protocol Matters TB-500 is the synthetic fragment of Thymosin Beta-4, a protein that the body naturally produces in response to tissue injury
US$ 29.83
US$ 26.66
US$ 22.83
